Institutional investors purchased a net $2.6 million shares of OHRP during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 35.72% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 703.9 Thousand shares of OHR Pharmaceutical Inc